- Education
-
Research
Current research
Talent
-
Collaboration
Businesses
Government agencies and institutions
Alumni
-
About AU
Organisation
Job at AU
Cardioversion of atrial fibrillation
2021.03.17 |
| Date | Fri 09 Apr |
| Time | 13:00 — 15:00 |
| Location | Online via Zoom |
On Friday 9 April at 13.00, Anders Sjørslev Schmidt defends his "Improving the efficacy and safety of direct current cardioversion".
Atrial fibrillation is the most common cardiac arrhtyhmia. The lifetime risk of atrial fibrillation is estimated to be 1 in 3 individuals. Atrial fibrillation is associated with other common lifestyle diseases such has hypertension and increases the risk of myocardial infarction and stroke. Direct-current cardioversion is a commonly performed procedure in the management of atrial fibrillation. This PhD project consisted of three randomized clinical trials. The aim of the trials was to investigate three clinical questions: Which devices, energy settings and electrode positions are resulting in the most successful outcome after cardioversion? The trials have contributed with important new evidence, which is directly useful for nurses and doctors as to guide clinical practise.
The summary is written by the PhD student.
The defence is public and takes place online via Zoom. Please read the attached press release for more information.
PhD student Anders Sjørslev Schmidt
Mail: as@clin.au.dk
Phone: (+45) 21243181